An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

September 2, 2015

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Non-Small Cell Lung Cancer
Trial Locations (26)

Unknown

Research Site, Khanti-Manskiysk

Research Site, Novisibirsk

Research Site, Arkhangelsk

Research Site, Barnaul

Research Site, Chelyabinsk

Research Site, Irkutsk

Research Site, Kemerovo

Research Site, Khabarovsk

Research Site, Kirov

Research Site, Krasnodar

Research Site, Krasnoyarsk

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Obninsk

Research Site, Omsk

Research Site, Orenburg

Research Site, Rostov-on-Don

Research Site, Saint Petersburg

Research Site, Samara

Research Site, Tambov

Research Site, Tomsk

Research Site, Ufa

Research Site, Vladivostok

Research Site, Volgograd

Research Site, Yuzhno-Sakhalinsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY